Medicament Surgipharm LLP

Key Details About Denosumab Injection:Uses: Treats postmenopausal osteoporosis, bone loss in men with prostate cancer, and bone loss in women with breast cancer receiving hormone therapy. It also treats certain giant cell tumors of the bone and hypercalcemia of malignancy.Brand Names & Types:Prolia (60 mg): Generally used for osteoporosis and bone loss treatments.Xgeva (120 mg): Generally used for cancer-related bone issues and giant cell tumors.Administration: Given as a subcutaneous injection (under the skin) in the thigh, abdomen, or upper arm by a healthcare professional, usually every 6 months for Prolia.Mechanism: As a RANK ligand inhibitor, it stops osteoclasts (bone-breaking cells) from forming, thus reducing bone resorption and increasing bone mass.Safety & Side Effects: Common side effects include back pain, pain in extremities, musculoskeletal pain, high cholesterol, and bladder infections. Serious but rare risks include osteonecrosis of the jaw (jawbone death) and atypical femoral fractures.Important Precautions: Patients should take calcium and vitamin D supplements, as the medication can cause low blood calcium (hypocalcemia). It is critical not to miss or delay doses, as this may increase the risk of vertebral fractures.